Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect?

Apogee Therapeutics Inc. (APGE) closed the last trading session at $53.97, gaining 46.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $93.11 indicates a 72.5% upside potential.The average comprises nine short-term price targets ranging from a low of $60.00 to a high of $116.00, with a standard deviation of $16.83. While the lowest estimate indicates an increase of 11.2% from the ...